Shanghai Minwei Biotechnology Co., Ltd

Primary objective: To evaluate the effectiveness of different doses of MWN101 injection in reducing body weight in obese subjects with moderate to severe obstructive sleep apnea (OSA). Secondary objectives: To evaluate the effectiveness of different doses of MWN101 injection in relieving OSA in obese subjects with moderate to severe obstructive sleep apnea (OSA); To evaluate the immunogenicity and safety of MWN101 injection in obese subjects with moderate to severe obstructive sleep apnea (OSA); To evaluate the pharmacokinetic characteristics of MWN101 injection in obese subjects with moderate to severe obstructive sleep apnea (OSA). To explore the safety, tolerability and pharmacokinetic characteristics of MWN101 injection after multiple administration of 30 mg.